Know Cancer

or
forgot password
  • cancer clinical trials in independence, OH

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Melanoma (Skin)
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Lymphoma
    4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Bladder Cancer
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Lymphoma
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Leukemia
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
    Cleveland Clinic Independence
    Independence, Ohio
    Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Breast Cancer
    S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
    Community Oncology Group - Independence
    Independence, Ohio 44131
    Adult Meningioma
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Community Oncology Group - Independence
    Independence, Ohio 44131
    Bladder Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Community Oncology Group - Independence
    Independence, Ohio 44131
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Community Oncology Group - Independence
    Independence, Ohio 44131
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Breast Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Lung Cancer
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Community Oncology Group - Independence
    Independence, Ohio 44131
    Leukemia
    S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)
    Community Oncology Group - Independence
    Independence, Ohio 44131
    Penile Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Lymphoma
    S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    Community Oncology Group - Independence
    Independence, Ohio 44131
    Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Pancreatic Cancer
    S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Head and Neck Cancer
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Head and Neck Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Melanoma (Skin)
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Breast Cancer
    S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Sarcoma
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Multiple Myeloma
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Sarcoma
    S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Breast Cancer
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Malignant Mesothelioma
    S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
    Community Oncology Group at Cleveland Clinic Cancer Center
    Independence, Ohio 44131
    Head and Neck Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Cleveland Clinic Cancer Center Independence
    Independence, Ohio 44131
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer